24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical genetics<br />

roborate the existence <strong>of</strong> a clinically recognizable group <strong>of</strong> AOS patients<br />

with psychomotor delay, mental retardation, central nervous system<br />

(CNS) manifestations and seizures . Furthermore, subependymal<br />

heterotopia, never reported before in AOS, broadens the phenotypic<br />

spectrum <strong>of</strong> CNS abnormalities to include neuronal migration defects .<br />

This severe variant <strong>of</strong> AOS, whose phenotype has been recently delineated,<br />

is likely inherited in autosomal recessive fashion . Hence, the<br />

importance <strong>of</strong> a timely diagnosis not only to manage CNS manifestations<br />

but also to properly counsel the families .<br />

P01.240<br />

Aplasia cutis congenita type iii, congenital scalp defects with<br />

distal limb reduction anomalies - Adams-Olivier syndrome.<br />

J. Paprocka 1 , E. Jamroz 1 , A. Pyrkosz 2 , A. Jezela-Stanek 3 , S. Hacia 4 , J. Baron 4 ,<br />

E. Marszał 1 ;<br />

1 Child Neurology Department, Silesian Medical University, Katowice 40-752,<br />

Poland, 2 Department <strong>of</strong> Molecular Biology and <strong>Genetics</strong>, Silesian Medical University,<br />

Katowice 40-752, Poland, 3 Department <strong>of</strong> Clinical <strong>Genetics</strong>, Memorial<br />

Children’s Health Institute, Warsaw, Poland, 4 Student’s Association at the Child<br />

Neurology Department, Silesian Medical University, Katowice 40-752, Poland.<br />

Aplasia cutis congenita (ACC) are the heterogeneous group <strong>of</strong> disorders<br />

with various clinical manifestations . Adams-Oliver syndrome<br />

(AOS, MIM 100300), a rare congenital disorder, belongs to the type III<br />

by Sybert classification <strong>of</strong> ACC, and is characterized by aplasia cutis<br />

congenita <strong>of</strong> the scalp and variable degrees <strong>of</strong> terminal transverse limb<br />

defects . Other associated anomalies include vascular defects: cutis<br />

marmorata, dilated scalp veins, small eyes, hypoplastic optic nerve,<br />

submucous cleft palate, cardiovascular and brain malformations (cortical<br />

malformations- polymicrogyria, encephalocoele, hypoplasia <strong>of</strong> the<br />

left arteria cerebri media) .<br />

Adams-Oliver syndrome is a genetic defect that causes a vasculopathy<br />

and leads to a variety <strong>of</strong> phenotypes . Inheritance <strong>of</strong> Adams-Olivier<br />

syndrome is autosomal dominant but there are also reports <strong>of</strong> possible<br />

autosomal recessive mode <strong>of</strong> inheritance .<br />

The authors present a 27-month-old-boy with phenotype <strong>of</strong> Adams-Olivier<br />

syndrome and Peter’s anomaly (central leukomata with variable<br />

iridocorneal and keratolenticular adhesions and cataract), refractory<br />

epilepsy and psychomotor retardation . The molecular investigation is<br />

ongoing in order to identify the genetic cause <strong>of</strong> AOS .<br />

P01.241<br />

manifestation <strong>of</strong> X-linked Adrenoleukodystrophy in<br />

heterozygous carriers<br />

S. V. Mikhaylova 1 , G. E. Rudenskaya 2 , N. Y. Kalinchenko 3 , O. V. Shekhter 2 ;<br />

1 Russian Children’s Hospital, Moscow, Russian Federation, 2 Research Centre<br />

for Medical <strong>Genetics</strong>, Moscow, Russian Federation, 3 Endocrinological Research<br />

Center, Moscow, Russian Federation.<br />

X-linked adrenoleukodystrophy (ALD, MIM 300100) has several phenotypes,<br />

clinical manifestation in women-heterozygous carriers among<br />

them . About 15_20% <strong>of</strong> carriers develop neurological signs, typically<br />

lower spastic paraparesis resembling adrenomyeloneuropathy (AMN)<br />

without adrenal insufficiency. After 40 yrs this proportion amounts<br />

50% . Though, ALD manifestation is women is <strong>of</strong>ten misdiagnosed . In<br />

our sample <strong>of</strong> 50 unrelated families with verified ALD there were two<br />

families with evident manifestation in women . Low proportion <strong>of</strong> these<br />

cases may be partly due to the young age <strong>of</strong> most mothers in the<br />

sample . In one family, 7-year-old proband had childhood cerebral ALD,<br />

in his younger brother presymptomatic stage <strong>of</strong> disease was found<br />

out . Their 26-year-old maternal uncle showed typical presentations <strong>of</strong><br />

AMN, 52-year-old grandmother had progressive spastic paraparesis<br />

since 35_40 yrs . Prior to ALD discovering in the proband they had diagnosis<br />

<strong>of</strong> Strumpell’s disease despite evident adrenal insufficiency in<br />

the uncle . In 3-year-old proband from another family ALD manifested<br />

by adrenal insufficiency as early as in 2.5 yrs, brain MRI proved childhood<br />

cerebral form . His 32-year-old mother and her monozygotic twin<br />

since 27 yrs suffered spastic paraparesis with bladder disturbances<br />

and normal MRI, their previous diagnosis was multiple sclerosis . Such<br />

cases along with reported earlier [Krenn et al, 2001; O’Neill et al, 2001;<br />

Shaw-Smith et al, 2004] point that women suspicious for Strumpell’s<br />

disease or familial multiple sclerosis should be tested for ALD if pedigree<br />

permits X-linked inheritance. Both families, particularly the first<br />

one, also support the known fact <strong>of</strong> diffferent ALD phenotypes intrafamilial<br />

co-existence .<br />

P01.242<br />

New mutations and sequence variations in galician patients with<br />

familiar Alzheimer´s Desease<br />

M. Garcia-Murias 1 , A. Robles 2 , G. Martínez-Nieto 1 , M. Arias 2 , A. Koukoulis 3 , B.<br />

Quintáns 4,5 , P. Blanco-Arias 6,5 , A. Sesar 2 , A. Carracedo 1,6,5 , M. Sobrido 1,5 ;<br />

1 Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela,<br />

Spain, 2 Department <strong>of</strong> Neurology, Hospital Clínico, Santiago de Compostela,<br />

Spain, 3 Department <strong>of</strong> Neurology, Hospital Xeral-Cíes, Vigo, Spain, 4 Hospital<br />

Clínico-SERGAS, Santiago de Compostela, Spain, 5 Centro Para Investigación<br />

en Red de Enfermedades Raras CIBERER, ISCIII, Santiago de Compostela,<br />

Spain, 6 Grupo de Medicina Xenómica-USC, Santiago de Compostela, Spain.<br />

Mutations in presenilin 1 (PSEN1) are detected in 30-70% <strong>of</strong> familiar<br />

Alzheimer disease (FAD) while presenilin 2 (PSEN2) and amyloid precursor<br />

protein (APP) mutations are much less frequent . We studied 61<br />

clinical-based cases with a diagnosis <strong>of</strong> probable FAD . We sequenced<br />

all coding exons <strong>of</strong> PSEN1 and PSEN2, as well as exons 16 and 17<br />

<strong>of</strong> APP on an ABI3730 sequencer . Sequence analysis was performed<br />

with the Staden package. A novel L424V mutation was identified in<br />

exon 12 <strong>of</strong> PSEN1 in a patient with very young onset dementia . Another<br />

new mutation, I408T, was identified in exon 11 <strong>of</strong> PSEN1 in a<br />

family . In two other cases <strong>of</strong> FAD missense mutations were detected in<br />

PSEN2: A415T and R435Q, both in exon 12 . Five patients showed intronic<br />

changes <strong>of</strong> unknown significance not reported in the searchable<br />

databases if human polymorphisms. We identified the single nucleotide<br />

substitution c .338+39G>A in intron 4 <strong>of</strong> PSEN1, a 6 bp deletion in<br />

intron 17 <strong>of</strong> APP and three intronic variants in PSEN2: c .119-31G>A<br />

(intron 4), c .887-19A>C (intron 8), c .1191+57T>A (intron 11) . A synonymous<br />

change (S236S) in PSEN2 was present in two individuals . All<br />

new mutations and sequence variations were screened in a panel <strong>of</strong><br />

186 Galician control individuals without neurological disorders . Globally<br />

mutations were detected in 6 .6% <strong>of</strong> the cases (18% if we consider<br />

both missense mutations and sequence variations <strong>of</strong> unknown significance)<br />

. This low frequency <strong>of</strong> mutations may be due to not very restrictive<br />

referring criteria . Alternatively, other genes may explain most FAD<br />

in our region .<br />

P01.243<br />

Left Ventricular Outflow Tract Obstructions (LVOTO): family data<br />

and NOTCH mutations<br />

W. S. Kerstjens-Frederikse, R. M. F. Berger, Y. J. Vos, R. M. W. H<strong>of</strong>stra;<br />

University Medical Center, Groningen, The Netherlands.<br />

Left ventricular outflow tract obstructions (LVOTO) are <strong>of</strong>ten familial.<br />

Early detection <strong>of</strong> (latent) LVOTO or increased familial risk can prevent<br />

unexpected cardiac death . To analyse the percentage <strong>of</strong> familial cases<br />

all new and known patients with left sided anomalies seen after april 1 st<br />

2006 by the department <strong>of</strong> pediatric cardiology (170) were <strong>of</strong>fered genetic<br />

counselling . Thirty-one patients refused genetic counseling, the<br />

others were seen by the same clinical geneticist . In 44 an aortic valve<br />

stenosis was diagnosed, in 21 a bicuspid aortic valve without stenosis,<br />

in 28 a hypoplastic left heart, in 67 an aortic coarctation and in 10 other<br />

left sided anomalies . In 17 patients the family history combined with<br />

ultrasound <strong>of</strong> first degree relatives revealed a LVOTO and in another<br />

19 probands a relative with yet another congenital heart defect was<br />

found .<br />

The first mutations in NOTCH1 were published in 2005 by Garg et<br />

al . in two families with bicuspid aortic valve and other heart defects,<br />

and so far two small series showed mutations in approximately 4% <strong>of</strong><br />

the patients. In our patient group, sequencing has been finished in 40<br />

patients, and 3 mutations have been found .<br />

We conclude that LVOTO is <strong>of</strong>ten familial and most pedigrees are<br />

compatible with autosomal dominant inheritance with incomplete penetrance<br />

. NOTCH1 mutations are found in a small percentage <strong>of</strong> familial<br />

and non-familial cases .<br />

P01.244<br />

Asymptomatic neurocutaneous melanosis: A case report and<br />

review <strong>of</strong> literature<br />

N. O. Dávalos 1,2 , V. M. Anguiano-Alvarez 3 , G. H. Galicia-Hernandez 3 , R.<br />

E´Vega 3,4 , D. A. Guzmán-Sánchez 5 , M. Gonzalez-Cruz 6 , M. E. Sánchez-Castellanos<br />

7 , J. C. Salas-Alanis 3 ;<br />

1 Instituto de Genética <strong>Human</strong>a, CUCS, Universidad de Guadalajara, Gudalajara,<br />

Mexico, 2 Hospital Valentin Gomez Farias, Servicio de Genética, ISSSTE.<br />

Guadalajara, Jalisco, México., Guadalajara, Mexico, 3 Instituto de Genética Hu-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!